AIMS: To assess and compare the anterior chamber depth (ACD) by different anterior segment imaging techniques. METHODS: Eighty healthy eyes of 40 patients were recruited, and 3 consecutive measurements of ACD were determined prospectively utilizing Visante optical coherence tomography (OCT), slitlamp (SL) OCT, IOL Master, Pentacam and Orbscan IIz. The statistical significance of interdevice differences between measurements was evaluated by one-way ANOVA and Bland-Altman analysis. The repeatability of 3 consecutive measurements was analyzed by repeated-measures ANOVA. RESULTS: The mean ACD was 2.98 ± 0.29, 2.85 ± 0.29, 3.33 ± 0.42, 2.93 ± 0.30 and 2.80 ± 0.29 mm with Visante OCT, SL-OCT, IOL Master, Pentacam and Orbscan IIz, respectively. All devices displayed a high intrasession repeatability (repeated-measures ANOVA, p > 0.05). ACD measurements obtained by the IOL Master were significantly greater compared to other devices. ACD values detected by Visante OCT and SL-OCT, Pentacam and Orbscan IIz were not clinically interchangeable, even though no statistically significant difference was detected. CONCLUSION: Although noncontact ACD measurements using all modalities were easy to handle and demonstrated good repeatability, the tested devices were not regarded as compatible. Hence, the clinician should take the different modalities into consideration during ACD assessment using various devices.
AIMS: To assess and compare the anterior chamber depth (ACD) by different anterior segment imaging techniques. METHODS: Eighty healthy eyes of 40 patients were recruited, and 3 consecutive measurements of ACD were determined prospectively utilizing Visante optical coherence tomography (OCT), slitlamp (SL) OCT, IOL Master, Pentacam and Orbscan IIz. The statistical significance of interdevice differences between measurements was evaluated by one-way ANOVA and Bland-Altman analysis. The repeatability of 3 consecutive measurements was analyzed by repeated-measures ANOVA. RESULTS: The mean ACD was 2.98 ± 0.29, 2.85 ± 0.29, 3.33 ± 0.42, 2.93 ± 0.30 and 2.80 ± 0.29 mm with Visante OCT, SL-OCT, IOL Master, Pentacam and Orbscan IIz, respectively. All devices displayed a high intrasession repeatability (repeated-measures ANOVA, p > 0.05). ACD measurements obtained by the IOL Master were significantly greater compared to other devices. ACD values detected by Visante OCT and SL-OCT, Pentacam and Orbscan IIz were not clinically interchangeable, even though no statistically significant difference was detected. CONCLUSION: Although noncontact ACD measurements using all modalities were easy to handle and demonstrated good repeatability, the tested devices were not regarded as compatible. Hence, the clinician should take the different modalities into consideration during ACD assessment using various devices.
Authors: Matthew T Feng; Michael W Belin; Renato Ambrósio; Satinder P S Grewal; Wang Yan; Mohamed S Shaheen; Charles McGhee; Naoyuki Maeda; Tobias H Neuhann; H Burkhard Dick; Saleh A Alageel; Andreas Steinmueller Journal: Saudi J Ophthalmol Date: 2011-04-30
Authors: Lorenzo Ismael Perez-Sanchez; Julia Gutierrez-Vazquez; Maria Satrustegui-Lapetra; Francisco Ferreira-Manuel; Juan Jose Arevalo-Manso; Juan Jesus Gomez-Herrera; Juan Jose Criado-Alvarez Journal: Int Ophthalmol Date: 2021-02-23 Impact factor: 2.031
Authors: Alberto Domínguez-Vicent; Cari Pérez-Vives; Teresa Ferrer-Blasco; Santiago García-Lázaro; Robert Montés-Micó Journal: Int J Ophthalmol Date: 2016-07-18 Impact factor: 1.779
Authors: Marcus Ang; Wesley Chong; Huiqi Huang; Wan Ting Tay; Tien Yin Wong; Ming-Guang He; Tin Aung; Jodhbir S Mehta Journal: PLoS One Date: 2013-06-04 Impact factor: 3.240